skeleton
• vertebral BMD is reduced by 16% compared to wild-type controls
|
• number and area of mineralized nodules are reduced in bone marrow stromal cells (BMSC)
|
• vertebral BMC is reduced by 30% compared to wild-type controls
|
cardiovascular system
• recovery of contractile function in DMSO-treated heart following ischemia-reperfusion injury is decreased as compared to wild-type (47 +/-5% vs 60 +/-7%)
• +dP/dt (derivative of change in contractile pressure over time) is decreased following ischemic-reperfusion injury in DMSO treated hearts
|
• -dP/dt (derivative of change in relaxation pressure over time) is increased as compared to wild-type following ischemic-reperfusion injury in DMSO treated hearts
|
• LVSP is decreased as compared to wild-type following ischemic-reperfusion injury in DMSO treated hearts
|
cellular
• mice exhibit an increase TUNEL-positive cells (indicator of late stage apoptosis) in non-ischemic hearts as compared to wild-type
• following ischemia-reperfusion injury mice exhibit an increase TUNEL-positive cells (indicator of late stage apoptosis) in DMSO- treated hearts as compared to wild-type
|
muscle
• recovery of contractile function in DMSO-treated heart following ischemia-reperfusion injury is decreased as compared to wild-type (47 +/-5% vs 60 +/-7%)
• +dP/dt (derivative of change in contractile pressure over time) is decreased following ischemic-reperfusion injury in DMSO treated hearts
|
• -dP/dt (derivative of change in relaxation pressure over time) is increased as compared to wild-type following ischemic-reperfusion injury in DMSO treated hearts
|
• mice exhibit an increase TUNEL-positive cells (indicator of late stage apoptosis) in non-ischemic hearts as compared to wild-type
• following ischemia-reperfusion injury mice exhibit an increase TUNEL-positive cells (indicator of late stage apoptosis) in DMSO- treated hearts as compared to wild-type
|